CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 439 enrolled
Drug / intervention
Sevabehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01963234
NCT01963234N/ACompleted
CompareCT.gov

Implementing Technology-Assisted Drug Treatment and Relapse Prevention in Federally Qualified Health Centers (FQHCs)

University of Wisconsin, Madison·interventional·Posted Oct 16, 2013·Updated Jul 31, 2018

In Brief

A clinical study evaluating Seva for Substance Use Disorders and HIV. Completed, enrolled 439 participants across 3 sites.

Detailed Summary

Implementing a mobile-phone based system for drug use disorders in primary care settings.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSubstance Use Disorders, HIV
CountriesUnited States
CollaboratorsNational Institute on Drug Abuse (NIDA), Dartmouth College, Center for Health Enhancement System Studies

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedOct 16, 2013
Enrollment StartMar 1, 2014
Primary CompletionJun 30, 2017
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 12.7 years ago

Interventions

Sevabehavioral

Patients were given access to use Seva. This is a mobile application that uses social and behavioral theories to help support people after alcohol use disorder recovery.